Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference3 articles.
1. Fujiwara, Y. & Kobayashi, K. Oncology drug clinical development and approval in Japan: the role of the pharmaceuticals and medical devices evaluation center (PMDEC). Crit. Rev. Oncol. Hematol. 42, 145–155 (2002).
2. Kagayama, K. & Ono, S. Actual performance of Japanese clinical development and regulatory review (2000-2014). Research Paper Series No. 68 (November 2015), Office of Pharmaceutical Industry Research, The Japan Pharmaceutical Manufacturers Association (in Japanese)
http://www.jpma.or.jp/opir/research/rs_068/article_068.html
(2015)
3. Fujiwara, Y., Yonemori, K., Shibata, T., Okita, N. & Ushirozawa, N. Japanese universal health care faces a crisis in cancer treatment. Lancet Oncol. 16, 251–252 (2015).
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献